Marks Mike A 4

What Happened

• Mike A. Marks, Executive Vice President and Chief Financial Officer of HCA Healthcare, was granted 11,945 stock appreciation rights (SARs) on January 29, 2026. The grant is reported as an award/acquisition (derivative) at a reporting price of $0.00 (no immediate cash outlay).

Key Details

• Transaction date and type: 2026-01-29 — Award/Grant of SARs (code A).
• Quantity and price: 11,945 SARs granted @ $0.00 (derivative award, not an open‑market purchase).
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnote: The SARs vest in four equal annual installments beginning January 29, 2027 (per footnote F1).
• Timeliness: Form 4 filed 2026-02-02; filing appears timely (filed within required business-day window).

Context

• SARs are a form of long‑term compensation that pay the holder the appreciation in stock price (in cash or stock) upon vesting/exercise; they do not represent immediate share purchases or sales. Such grants are common executive compensation and do not by themselves indicate the insider is buying or selling stock for investment reasons. The multi-year vesting schedule ties potential value to future company performance.